Search results
Novavax (NASDAQ:NVAX) Trading 3.5% Higher
ETF DAILY NEWS· 2 weeks agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report)’s stock price traded up 3.5% during mid-day trading on Friday . The stock traded as high ...
Shah Capital proposes new directors for Novavax board By Investing.com
Investing.com· 2 weeks agoShah Capital, holding a 6.7% stake in vaccine developer Novavax Inc. (NASDAQ: NASDAQ:NVAX), today...
Better Buy: Bluebird Bio Vs. Novavax
Motley Fool via Yahoo Finance· 2 weeks agoIf it can grab a small slice of its target market with Lyfgenia, its stock price could soar. The case for Novavax Novavax is also a pretty ...
Novavax investor Shah Capital pushes for board shakeup
Reuters via AOL· 2 weeks ago(Reuters) -A top shareholder of COVID-19 vaccine maker Novavax on Monday said the company has been...
Activist investor blasts Novavax for not using mRNA fears to boost COVID-19 vaccine sales
Quartz· 2 weeks agoThe activist hedge fund Shah Capital blasted the leadership of Novavax for not leveraging concerns...
Raleigh hedge fund urges board shakeup at Novavax - Triangle Business Journal
The Business Journals· 2 weeks agoA Raleigh-based hedge fund is pushing for changes at a struggling vaccine developer. The investment...
Shah Capital nominates two highly qualified independent director candidates for Novavax - Novavax...
Benzinga· 2 weeks agoBelieves the two new nominated directors possess the necessary experience to tackle the underperformance of the business which will improve its share price Shah Capital which owns 6.7% of Novavax, in a letter to
Hedge fund Shah Capital recommends two new candidates for Novavax board
WSAU Wausau· 2 weeks ago(Reuters) - U.S.-based hedge fund Shah Capital on Monday recommended the appointment of two new independent directors to the Novavax board. The hedge fund named Suresh Katta ...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 2 days agoModerna stock went public at 23 in late 2018. In 2020, shares rocketed more than 434%. ...share. The...
These Biotech Stocks Could Soar 120% and 295%, According to Wall Street
Motley Fool via Yahoo Finance· 5 days agoBut even if Iovance stock doesn't soar that quickly, it still represents a solid long-term buy. 2. ...